Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

1.

Short-term effects of bimatoprost in glaucoma patients from an outpatient clinic.

Iester M, Perdicchi A, Venturino G, Rolando M, Traverso CE, Leonardi E, Calabria G.

J Ocul Pharmacol Ther. 2004 Oct;20(5):393-400.

PMID:
15650514
[PubMed - indexed for MEDLINE]
2.

Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.

Rossetti L, Karabatsas CH, Topouzis F, Vetrugno M, Centofanti M, Boehm A, Viswanathan A, Vorwerk C, Goldblum D.

Ophthalmology. 2007 Dec;114(12):2244-51. Epub 2007 Apr 25.

PMID:
17459480
[PubMed - indexed for MEDLINE]
3.

Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients.

Konstas AG, Katsimbris JM, Lallos N, Boukaras GP, Jenkins JN, Stewart WC.

Ophthalmology. 2005 Feb;112(2):262-6.

PMID:
15691561
[PubMed - indexed for MEDLINE]
4.

Comparative evaluation of bimatoprost monotherapy in primary chronic angle closure and primary open angle glaucoma eyes: a three-year study.

Gupta V, Srinivasan G, Sharma A, Kapoor KS, Sihota R.

J Ocul Pharmacol Ther. 2007 Aug;23(4):351-8.

PMID:
17803433
[PubMed - indexed for MEDLINE]
5.

Long-term IOP lowering with bimatoprost in open-angle glaucoma patients poorly responsive to latanoprost.

Sonty S, Donthamsetti V, Vangipuram G, Ahmad A.

J Ocul Pharmacol Ther. 2008 Oct;24(5):517-20. doi: 10.1089/jop.2008.0033.

PMID:
18800869
[PubMed - indexed for MEDLINE]
6.

Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization.

Law SK, Song BJ, Fang E, Caprioli J.

Ophthalmology. 2005 Dec;112(12):2123-30. Epub 2005 Oct 12.

PMID:
16225924
[PubMed - indexed for MEDLINE]
7.

[Bimatoprost in the treatment of ocular hypertension and chronic glaucoma].

Detry-Morel M.

J Fr Ophtalmol. 2005 Mar;28(3):285-9. French.

PMID:
15883493
[PubMed - indexed for MEDLINE]
Free Article
8.

A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma.

Dirks MS, Noecker RJ, Earl M, Roh S, Silverstein SM, Williams RD.

Adv Ther. 2006 May-Jun;23(3):385-94.

PMID:
16912020
[PubMed - indexed for MEDLINE]
9.

Comparison of the ocular hypotensive effects of bimatoprost and timolol-dorzolamide combination in patients with elevated intraocular pressure: a 6-month study.

Ozturk F, Ermis SS, Inan UU.

Acta Ophthalmol Scand. 2007 Feb;85(1):80-3.

PMID:
17244215
[PubMed - indexed for MEDLINE]
10.

Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial.

Koz OG, Ozsoy A, Yarangumeli A, Kose SK, Kural G.

Acta Ophthalmol Scand. 2007 Dec;85(8):838-43. Epub 2007 Aug 2.

PMID:
17680841
[PubMed - indexed for MEDLINE]
11.

Evaluation of circadian control of intraocular pressure after a single drop of bimatoprost 0.03% or travoprost 0.004%.

Frenkel RE, Noecker RJ, Craven ER.

Curr Med Res Opin. 2008 Apr;24(4):919-23. doi: 10.1185/030079908X273381 . Epub 2008 Feb 8.

PMID:
18267054
[PubMed - indexed for MEDLINE]
12.

Comparison of the effects of latanoprost and bimatoprost on intraocular pressure in chronic angle-closure glaucoma.

Chen MJ, Chen YC, Chou CK, Hsu WM.

J Ocul Pharmacol Ther. 2007 Dec;23(6):559-66.

PMID:
18001247
[PubMed - indexed for MEDLINE]
13.

Efficacy, tolerability and safety of the fixed combination of bimatoprost 0.03% and timolol 0.5% in a broad patient population: multicenter, open-label observational study.

Feuerhake C, Buchholz P, Kimmich F.

Curr Med Res Opin. 2009 Apr;25(4):1037-43. doi: 10.1185/03007990902816947 .

PMID:
19290780
[PubMed - indexed for MEDLINE]
14.

Comparing bimatoprost and travoprost in black Americans.

Noecker RJ, Earl ML, Mundorf TK, Silverstein SM, Phillips MP.

Curr Med Res Opin. 2006 Nov;22(11):2175-80.

PMID:
17076978
[PubMed - indexed for MEDLINE]
15.

Effects of the combination of bimatoprost and latanoprost on intraocular pressure in primary open angle glaucoma: a randomised clinical trial.

Doi LM, Melo LA Jr, Prata JA Jr.

Br J Ophthalmol. 2005 May;89(5):547-9.

PMID:
15834081
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Incidence of hyperemia associated with bimatoprost treatment in naïve subjects and in subjects previously treated with latanoprost.

Kurtz S, Mann O.

Eur J Ophthalmol. 2009 May-Jun;19(3):400-3.

PMID:
19396785
[PubMed - indexed for MEDLINE]
17.

Effect of changing from concomitant timolol pilocarpine to bimatoprost monotherapy on ocular blood flow and IOP in primary chronic angle closure glaucoma.

Agarwal HC, Gupta V, Sihota R.

J Ocul Pharmacol Ther. 2003 Apr;19(2):105-12.

PMID:
12804055
[PubMed - indexed for MEDLINE]
18.

A 12-week study evaluating the efficacy of bimatoprost 0.03% in patients with pseudoexfoliative and open-angle glaucoma.

Ciancaglini M, Carpineto P, Agnifili L, Nubile M, Toto L, Mastropasqua L.

Eur J Ophthalmol. 2009 Jul-Aug;19(4):594-600.

PMID:
19551674
[PubMed - indexed for MEDLINE]
19.
20.

Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.

Orzalesi N, Rossetti L, Bottoli A, Fogagnolo P.

Ophthalmology. 2006 Feb;113(2):239-46.

PMID:
16458092
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk